Marc Forth
Vermogen: 288 076 $ op 31-08-2026
Vermogen: 288 076 $ op 31-08-2026
Marc Forth is currently Chief Executive Officer & Director at Jeune Aesthetics, Inc. since 2025 and Director at AEON Biopharma, Inc. since 2025.
Formerly, Mr. Forth was Vice President-Sales & Marketing Urology at Allergan UC from 2011 to 2014.
Education includes undergraduate studies at Southern Methodist University and California State University-Fresno.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-06-2026 | 973.231 ( 1,95% ) | 288 076 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AEON BIOPHARMA, INC. | Directeur/Bestuurslid | 01-06-2023 |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Algemeen Directeur | 07-04-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California State University-Fresno
California State University-Fresno Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
AEON Biopharma, Inc.
AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau